share_log

JP Morgan Downgrades Editas Medicine to Underweight

JP Morgan Downgrades Editas Medicine to Underweight

摩根大通将Editas Medicine评级下调至减持
Benzinga ·  05:23

JP Morgan analyst Brian Cheng downgrades Editas Medicine (NASDAQ:EDIT) from Neutral to Underweight.

JP摩根的分析师Brian Cheng将Editas Medicine(纳斯达克:EDIT)评级从中立下调至减持。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发